Clinical Value of Proton Pump Inhibitor Combined with Aluminum Magnesium Suspension in the Treatment of Gastric Endoscopic Mucosal Ulcer
Objective To study the effect of proton pump inhibitor combined with aluminum magnesium suspension in the treatment of gastric endoscopic mucosal ulcer.Methods A total of 80 patients with gastric endoscopic mucosal ulcer diagnosed and treated in our hospital from January 2021 to December 2022 were selected as the research objects.They were divided into control group and observation group by random number table method,with 40 patients in each group.The control group was treated with proton pump inhibitors,and the observation group was treated with aluminum magnesium plus suspension on the basis of the control group.The clinical efficacy,incidence of delayed bleeding,ulcer area,gastrointestinal symptom score(GSRS),and incidence of adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was 95.00％,which was higher than 80.00％in the control group(P＜0.05).The incidence of delayed bleeding in the observation group was 5.00％,which was lower than 12.50％in the control group(P＜0.05).After 2 and 4 weeks of treatment,the ulcer area of the observation group was smaller than that of the control group,and the GSRS score was lower than that of the control group(P＜0.05).There was no significant difference in the incidence of adverse reactions between the observation group and the control group(P＞0.05).Conclusion Proton pump inhibitor combined with aluminum magnesium suspension can improve the therapeutic effect of gastric endoscopic mucosal ulcer,reduce gastrointestinal symptoms,the incidence of delayed bleeding and the ulcer area,and will not increase adverse reactions,the application safety is high.
万方数据
维普
